VERMODJE – Boldever
|250mg/ml - 10ml vial
|Men 400 - 1000 mg/week
Boldenone undecylenate, also known as Equipoise, is an androgen and anabolic steroid (AAS) drug used in veterinary medicine, mostly in horses. It is marketed under the trade names Parenabol as well as among others. In the past, it was also applied to people. It is injected into the muscle.
In the 1960s, boldenone undecylenate was made available for medicinal usage. Boldenone undecylenate is utilised for purposes other than medicine, such as enhancing performance and appearance. In the United States, the drug is a restricted substance, and use of it is often illegal. In Australia and the US, it is still sold for veterinary use.
Why choose Boldenone undecylenateover conventional medicine?
Boldenone undecylenate, a prodrug of boldenone, is an androgen receptor agonist. Both its anabolic and androgenic effects are significant with boldenone. Additionally, it has little or no progestogenic action and minimal estrogenic activity. Boldenone and boldenone undecylenate have minimal to no risk of hepatotoxicity since they are not 17-alkylated.
The medication acts as an agonist of the androgen receptor (AR), which is the biological target of androgens like testosterone and dihydrotestosterone. It is a synthetic androgen and anabolic steroid (DHT). There is no danger of liver damage, no risk of estrogenic side effects, mild androgenic effects, and high anabolic effects. In the body, boldenone undecylenate is an androgen ester and a persistent prodrug of boldenone.
Boldenone undecylenate was once utilised in human clinical practise, but it has since been stopped. The Food and Drug Administration has not yet given the medication its approval. Additionally, the DEA lists it as a Schedule III restricted drug. The dosage for horses is 0.5 mg per pound of body weight intramuscularly. Treatment may be repeated at three week intervals.
- masculinization like acne
- voice changes
- increased hair growth
- increased sexual desire